CHAF1B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.534420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.511200E-01
Normal-vs-Stage2
1.460280E-02
Normal-vs-Stage3
9.132400E-02
Normal-vs-Stage4
4.293800E-02
Stage1-vs-Stage2
3.997400E-01
Stage1-vs-Stage3
4.840000E-01
Stage1-vs-Stage4
1.913570E-01
Stage2-vs-Stage3
6.366800E-01
Stage2-vs-Stage4
1.037550E-01
Stage3-vs-Stage4
2.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.358330E-02
Normal-vs-AfricanAmerican
2.535600E-01
Normal-vs-Asian
1.416040E-01
Caucasian-vs-AfricanAmerican
4.337200E-01
Caucasian-vs-Asian
2.809600E-01
AfricanAmerican-vs-Asian
9.873200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.818100E-03
Normal-vs-Female
5.207800E-02
Male-vs-Female
1.077840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.489390E-01
Normal-vs-Age(41-60Yrs)
4.360400E-02
Normal-vs-Age(61-80Yrs)
9.599900E-03
Normal-vs-Age(81-100Yrs)
1.414630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.278800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.855200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.830800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.930800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.599200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.616000E-02
Normal-vs-Daily Drinker
1.723760E-02
Normal-vs-Weekly Drinker
2.784600E-01
Normal-vs-Occasional Drinker
1.530170E-02
Normal-vs-Social Drinker
8.766200E-02
Non Drinker-vs-Daily Drinker
2.411400E-01
Non Drinker-vs-Weekly Drinker
4.701800E-01
Non Drinker-vs-Occasional Drinker
2.170600E-01
Non Drinker-vs-Social Drinker
8.724800E-01
Daily Drinker-vs-Weekly Drinker
1.298790E-01
Daily Drinker-vs-Occasional Drinker
9.085800E-01
Daily Drinker-vs-Social Drinker
2.440800E-01
Weekly Drinker-vs-Occasional Drinker
1.258200E-01
Weekly Drinker-vs-Social Drinker
6.236400E-01
Occasional Drinker-vs-Social Drinker
2.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.872600E-01
Normal-vs-Grade 2
7.044000E-01
Normal-vs-Grade 3
7.676600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.326800E-01
Grade 1-vs-Grade 3
4.799800E-02
Grade 1-vs-Grade 4
6.872600E-01
Grade 2-vs-Grade 3
5.532000E-02
Grade 2-vs-Grade 4
7.044000E-01
Grade 3-vs-Grade 4
7.676600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.503630E-02
Normal-vs-NonDiabetic
2.112400E-02
Diabetic-vs-NonDiabetic
1.423230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.170800E-01
Normal-vs-NoPancreatitis
1.226380E-02
Pancreatitis-vs-NoPancreatitis
1.994820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.934100E-02
Normal-vs-N1
9.920900E-03
N0-vs-N1
9.063800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.474400E-01
Normal-vs-TP53-NonMutant
4.355000E-01
TP53-Mutant-vs-TP53-NonMutant
1.749640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
